M. Abalos-aguilera

SAT0331 Inflammatory markers and adipokines related to cardiovascular risk and metabolic comorbidities in psoriatic arthritis. in vivo effects of apremilast

N. Barbarroja, Y. Jiménez-Gómez, I. Arias de la Rosa, 2018, Saturday, 16 JUNE 2018.

FRI0156 An antimicrobial mechanism, netosis, is potentially involved in ankylosing spondylitis pathogenesis

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2018, FRIDAY, 15 JUNE 2018.

FRI0056 Altered Microrna Expression Pattern in Synovial and Blood Neutrophils in Rheumatoid Arthritis Reveals The Pathogenic Profile of These Cells

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2016 .

Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.

N. Barbarroja, C. López-Pedrera, R. Ortega-Castro, 2023, Journal of autoimmunity.

THU0218 Circulating micrornas as biomarkers for diagnosis and typifying the atherothrombotic status in antiphospholipid syndrome

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2017 .

FRI0046 TCZ Attenuates Atherothrombosis through The Specific Inhibition of Netosis and Monocyte-Mediated Proinflammatory Activity

N. Barbarroja, P. Ruiz-Limón, Y. Jiménez-Gómez, 2016 .

FRI0429 Dysregulation of the splicing machinery in leukocytes from ankylosing spondylitis patients is associated to disease pathogenesis

N. Barbarroja, P. Ruiz-Limón, P. Giannoudis, 2017 .